Staying Connected to Capital and Investors

"In Cooley’s Q4 2021 Venture Financing Report, the firm reported that it handled 82 disclosable financings of life sciences companies, representing more than $5.2 billion of invested capital. Deal sizes spiked, with an average deal size of more than $63 million in the quarter. Meanwhile, in a signal of investor caution, the percentage of life sciences transactions structured in tranches increased to more than 17% of deals, doubling from the prior quarter."

Read the article